Euphoriants | wpd11

Submitted by aua on 2025.10.30. - 03:50

vf_node_title_variants

MAGYAR CÍM	---	4607
ANGOL CÍM	Euphoriants	10667
NÉMET CÍM	---	15941
OROSZ CÍM	---	22508

vf_node_webs

	title (web)	field_t_title_web
	https://en.wikipedia.org/wiki/Template:Euphoriants

vf_node_items

	vf_node_pictures_all	title (item)	field_cer_web	field_cer_navbox	g_geofield	field_t_coordinates
		γ-Hidroxivajsav (GHB, gamma-hidroxibutirát, gamma-hidroxi-vajsav, Gina)	https://hu.wikipedia.org/wiki/Γ-Hidroxivajsav https://en.wikipedia.org/wiki/Γ-Hydroxybutyric_acid https://de.wikipedia.org/wiki/4-Hydroxybutansäure https://ru.wikipedia.org/wiki/Гамма-оксимасляная_кислота

body

Euphoriants
μ-Opioid receptor agonists (opioids) (e.g., morphine, heroin, hydrocodone, oxycodone, opium, kratom) • α2δ subunit-containing voltage-dependent calcium channels blockers (gabapentinoids) (e.g., gabapentin, pregabalin, phenibut) • AMPA receptor antagonists (e.g., perampanel) • CB1 receptor agonists (cannabinoids) (e.g., THC, cannabis) • Dopamine receptor agonists (e.g., levodopa) • Dopamine releasing agents (e.g., amphetamine, methamphetamine, MDMA, mephedrone) • Dopamine reuptake inhibitors (e.g., cocaine, methylphenidate) • GABAA receptor positive allosteric modulators (e.g., barbiturates, benzodiazepines, carbamates, ethanol (alcohol) (alcoholic drink), inhalants, nonbenzodiazepines, quinazolinones) • GHB (sodium oxybate) and analogues • Glucocorticoids (corticosteroids) (e.g., dexamethasone, prednisone) • nACh receptor agonists (e.g., nicotine, tobacco, arecoline, areca nut) • Nitric oxide prodrugs (e.g., alkyl nitrites (poppers)) • NMDA receptor antagonists (e.g., DXM, ketamine, methoxetamine, nitrous oxide, phencyclidine, inhalants) • Orexin receptor antagonists (e.g., suvorexant)
See also: Recreational drug use

Euphoriants

μ-Opioid receptor agonists (opioids) (e.g., morphine, heroin, hydrocodone, oxycodone, opium, kratom) • α2δ subunit-containing voltage-dependent calcium channels blockers (gabapentinoids) (e.g., gabapentin, pregabalin, phenibut) • AMPA receptor antagonists (e.g., perampanel) • CB1 receptor agonists (cannabinoids) (e.g., THC, cannabis) • Dopamine receptor agonists (e.g., levodopa) • Dopamine releasing agents (e.g., amphetamine, methamphetamine, MDMA, mephedrone) • Dopamine reuptake inhibitors (e.g., cocaine, methylphenidate) • GABAA receptor positive allosteric modulators (e.g., barbiturates, benzodiazepines, carbamates, ethanol (alcohol) (alcoholic drink), inhalants, nonbenzodiazepines, quinazolinones) • GHB (sodium oxybate) and analogues • Glucocorticoids (corticosteroids) (e.g., dexamethasone, prednisone) • nACh receptor agonists (e.g., nicotine, tobacco, arecoline, areca nut) • Nitric oxide prodrugs (e.g., alkyl nitrites (poppers)) • NMDA receptor antagonists (e.g., DXM, ketamine, methoxetamine, nitrous oxide, phencyclidine, inhalants) • Orexin receptor antagonists (e.g., suvorexant)